DABIGATRAN ETEXILATE: NEW DIRECT THROMBIN INHIBITORS ANTICOAGULANTS 

Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2011, Vol 2, Issue 4

Abstract

Thrombin plays a key role in thrombotic events, and therefore thrombin inhibition represents a therapeutic target for numerous thromboembolic diseases. Thrombin is responsible for the conversion of soluble fibrinogen to fibrin; clot stabilization through activation of factor XIII and the formation of cross-linkage among fibrin molecules; and the generation of additional thrombin through activation of factors V, VIII, and XI. Direct thrombin inhibitors are an innovative class of anticoagulants that bind directly to thrombin to inhibit its actions and impede the clotting process. Dabigatran is the first direct thrombin inhibitor, orally available first approval by US Food and Drugs Administration in 2010. Specifically and reversibly inhibits thrombin, so the duration of action is predictable. The anticoagulant effect correlates well with plasma drug concentrations, which implies an effective anticoagulation with low bleeding risk without major problems of interactions with other drugs. The predictable pharmacokinetics and pharmacodynamics characteristics of dabigatran may facilitate dental management of patients who until now have been in treatment with traditional anticoagulants, given that it doesn’t require routine laboratory monitoring in the vast majority of patients treated. They also present a profile of drug interactions very favorable. 

Authors and Affiliations

Hiren Mehta , Paresh Patel , Varsha Galani , Kinjal Patel

Keywords

Related Articles

FORMULATION AND EVALUATION OF SOLID DISPERSION OF LOPINAVIR BY USING DIFFERENT TECHNIQUES  

Poor aqueoussolubility is the major drawback for the various types of drugs and many approaches have been introduced for the enhancement of solubility of such drugs. Solid dispersion is one of the technique adopted for t...

AN OVERVIEW OF GASTRORETENTIVE DRUG DELIVERY SYSTEM RESEARCH 

The reason of writing this research article on gastro retentive drug delivery systems was to gather the recent literature with special focus on various gastro retentive approaches that have recently become leading method...

NEUROPHARMACOLOGICAL SCREENING OF THE IYENGARIA STELLATA REVEALED ITS MEMORY BOOSTING, ANXIOLYTIC AND ANTIDEPRESSANT EFFECTS 

Seaweeds are known to possess enormous biological activities. They contain variety of active constituents which have pharmacological significance. The objective of this study is to explore neuropharmacological activities...

EVALUATION OF ANTHELIMINTIC ACTIVITY IN THE BARK OF Homalium zeylanicum  

The main aim of the study was to investigate Phytoconstituents and antihelmintic activity in the bark extract of Homalium zeylanicum. All phytochemical screening methods were done by using standards methods, were as anti...

ETHNOPHARMACOLOGICAL POTENTIAL OF CALOTROPIS PROCERA: AN OVERVIEW 

The herbal medicine occupy distinct position right from ancient period. The plant Calotropis procera is known by different names in different part of the world. It is a wild growing medicinal plant distributed throughou...

Download PDF file
  • EP ID EP108512
  • DOI -
  • Views 105
  • Downloads 0

How To Cite

Hiren Mehta, Paresh Patel, Varsha Galani, Kinjal Patel (2011). DABIGATRAN ETEXILATE: NEW DIRECT THROMBIN INHIBITORS ANTICOAGULANTS . International Research Journal of Pharmacy (IRJP), 2(4), 50-55. https://europub.co.uk/articles/-A-108512